Tyche Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Sell
11,441
-3,142
-22% -$363K 0.21% 91
2025
Q4
$1.53M Buy
14,583
+6,549
+82% +$615K 0.24% 84
2025
Q3
$674K Sell
8,034
-105
-1% -$8.65K 0.12% 134
2025
Q2
$644K Sell
8,139
-1,618
-17% -$129K 0.13% 128
2025
Q1
$876K Sell
9,757
-2,999
-24% -$280K 0.19% 83
2024
Q4
$1.27M Buy
12,756
+4,991
+64% +$515K 0.27% 70
2024
Q3
$882K Sell
7,765
-68
-0.9% -$8.08K 0.2% 78
2024
Q2
$970K Sell
7,833
-1,609
-17% -$207K 0.24% 72
2024
Q1
$1.25M Sell
9,442
-3,726
-28% -$459K 0.3% 66
2023
Q4
$1.44M Buy
+13,168
New +$1.37M 0.35% 58

Other funds holding MRK

Tyche Wealth Partners's MRK Position: Q1 2026 in Review

Tyche Wealth Partners reduced its Merck (MRK) stake by 22% in Q1 2026, selling an estimated $363K and leaving 11,441 shares worth $1.38M. The position accounts for 0.21% of the portfolio, ranked #91.

Tyche Wealth Partners first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.53M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tyche Wealth Partners held 11,441 shares of Merck worth $1.38M as of Q1 2026.
  • Tyche Wealth Partners sold 3,142 Merck shares in Q1 2026, an estimated $363K.
  • Merck made up 0.21% of Tyche Wealth Partners's portfolio in Q1 2026, its #91 holding.
  • Tyche Wealth Partners first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Tyche Wealth Partners's Merck position peaked at $1.53M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.